Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.96 AUD | -1.25% |
|
+3.82% | -6.50% |
Jun. 18 | Clinuvel Pharmaceuticals' Afamelanotide Found Effective in Fair-Skinned Parkinson’s Patients | MT |
Jun. 18 | CLINUVEL Announces A Novel Clinical Program | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.50% | 506M | |
+1.43% | 94.45B | |
-1.71% | 38.9B | |
-12.83% | 32.56B | |
-12.14% | 15.98B | |
-0.68% | 13.82B | |
-12.63% | 11.34B | |
+163.45% | 9.81B | |
-53.23% | 9.67B | |
+3.52% | 8.91B |
- Stock Market
- Equities
- CUV Stock
- News Clinuvel Pharmaceuticals Limited
- Clinuvel Pharmaceuticals Partners Valentech Pharma to Introduce EPP Drug in Latin America